208 related articles for article (PubMed ID: 21540093)
1. Spanlastics--a novel nanovesicular carrier system for ocular delivery.
Kakkar S; Kaur IP
Int J Pharm; 2011 Jul; 413(1-2):202-10. PubMed ID: 21540093
[TBL] [Abstract][Full Text] [Related]
2. Development and evaluation of novel surfactant-based elastic vesicular system for ocular delivery of fluconazole.
Kaur IP; Rana C; Singh M; Bhushan S; Singh H; Kakkar S
J Ocul Pharmacol Ther; 2012 Oct; 28(5):484-96. PubMed ID: 22694593
[TBL] [Abstract][Full Text] [Related]
3. A novel nanovesicular carrier system to deliver drug topically.
Kakkar S; Kaur IP
Pharm Dev Technol; 2013; 18(3):673-85. PubMed ID: 22612232
[TBL] [Abstract][Full Text] [Related]
4. Enhanced corneal permeation and antimycotic activity of itraconazole against Candida albicans via a novel nanosystem vesicle.
ElMeshad AN; Mohsen AM
Drug Deliv; 2016 Sep; 23(7):2115-2123. PubMed ID: 25080226
[TBL] [Abstract][Full Text] [Related]
5. Design and optimization of surfactant-based nanovesicles for ocular delivery of Clotrimazole.
Basha M; Abd El-Alim SH; Shamma RN; Awad GE
J Liposome Res; 2013 Sep; 23(3):203-10. PubMed ID: 23607316
[TBL] [Abstract][Full Text] [Related]
6. Niosomes vs microemulsions: new carriers for topical delivery of Capsaicin.
Tavano L; Alfano P; Muzzalupo R; de Cindio B
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):333-9. PubMed ID: 21684725
[TBL] [Abstract][Full Text] [Related]
7. Preparation and evaluation of reverse-phase evaporation and multilamellar niosomes as ophthalmic carriers of acetazolamide.
Guinedi AS; Mortada ND; Mansour S; Hathout RM
Int J Pharm; 2005 Dec; 306(1-2):71-82. PubMed ID: 16263229
[TBL] [Abstract][Full Text] [Related]
8. Solid lipid nanoparticles for ocular drug delivery.
Seyfoddin A; Shaw J; Al-Kassas R
Drug Deliv; 2010; 17(7):467-89. PubMed ID: 20491540
[TBL] [Abstract][Full Text] [Related]
9. Intraocular distribution of topically applied hydrophilic and lipophilic substances in rat eyes.
Abdul Nasir NA; Agarwal P; Agarwal R; Iezhitsa I; Alyautdin R; Nukolova NN; Chekhonin VP; Mohd Ismail N
Drug Deliv; 2016 Oct; 23(8):2765-2771. PubMed ID: 26289215
[TBL] [Abstract][Full Text] [Related]
10. Terbinafine Hydrochloride Trans-ungual Delivery via Nanovesicular Systems: In Vitro Characterization and Ex Vivo Evaluation.
Elsherif NI; Shamma RN; Abdelbary G
AAPS PharmSciTech; 2017 Feb; 18(2):551-562. PubMed ID: 27138036
[TBL] [Abstract][Full Text] [Related]
11. Novel pH-sensitive non-ionic surfactant vesicles: comparison between Tween 21 and Tween 20.
Di Marzio L; Marianecci C; Petrone M; Rinaldi F; Carafa M
Colloids Surf B Biointerfaces; 2011 Jan; 82(1):18-24. PubMed ID: 20832262
[TBL] [Abstract][Full Text] [Related]
12. Spanlastics gel-A novel drug carrier for transdermal delivery of glimepiride.
Elsaied EH; Dawaba HM; Ibrahim ESA; Afouna MI
J Liposome Res; 2023 Mar; 33(1):102-114. PubMed ID: 35862551
[TBL] [Abstract][Full Text] [Related]
13. Spanlastics a Novel Nanovesicular Carrier: Its Potential Application and Emerging Trends in Therapeutic Delivery.
Ansari MD; Saifi Z; Pandit J; Khan I; Solanki P; Sultana Y; Aqil M
AAPS PharmSciTech; 2022 Apr; 23(4):112. PubMed ID: 35411425
[TBL] [Abstract][Full Text] [Related]
14. A controlled-release ocular delivery system for ibuprofen based on nanostructured lipid carriers.
Li X; Nie SF; Kong J; Li N; Ju CY; Pan WS
Int J Pharm; 2008 Nov; 363(1-2):177-82. PubMed ID: 18706987
[TBL] [Abstract][Full Text] [Related]
15. Hyalugel-integrated liposomes as a novel ocular nanosized delivery system of fluconazole with promising prolonged effect.
Moustafa MA; Elnaggar YSR; El-Refaie WM; Abdallah OY
Int J Pharm; 2017 Dec; 534(1-2):14-24. PubMed ID: 28987453
[TBL] [Abstract][Full Text] [Related]
16. Bioavailability and anticataract effects of a topical ocular drug delivery system containing disulfiram and hydroxypropyl-beta-cyclodextrin on selenite-treated rats.
Wang S; Li D; Ito Y; Nabekura T; Wang S; Zhang J; Wu C
Curr Eye Res; 2004 Jul; 29(1):51-8. PubMed ID: 15370367
[TBL] [Abstract][Full Text] [Related]
17. Chitosan/sulfobutylether-β-cyclodextrin nanoparticles as a potential approach for ocular drug delivery.
Mahmoud AA; El-Feky GS; Kamel R; Awad GE
Int J Pharm; 2011 Jul; 413(1-2):229-36. PubMed ID: 21540097
[TBL] [Abstract][Full Text] [Related]
18. Spanlastics: a novel elastic drug delivery system with potential applications via multifarious routes of administration.
Saini H; Rapolu Y; Razdan K; Nirmala ; Sinha VR
J Drug Target; 2023 Dec; 31(10):999-1012. PubMed ID: 37926975
[TBL] [Abstract][Full Text] [Related]
19. Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery.
Jiao J
Adv Drug Deliv Rev; 2008 Dec; 60(15):1663-73. PubMed ID: 18845195
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of puerarin-dendrimer complexes as an ocular drug delivery system.
Yao W; Sun K; Mu H; Liang N; Liu Y; Yao C; Liang R; Wang A
Drug Dev Ind Pharm; 2010 Sep; 36(9):1027-35. PubMed ID: 20545508
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
